The first studies described gene expression patterns that could be used to distinguish leukemic blast lineages [11,12], and subsequent studies identified various gene expression signatures characterizing relevant clinical leukemia subtypes, in particular the E2A/PBX1, BCR/ABL, TEL/AML1 and MLL rearrangements [13-15]. This evidence concerns the gene ETV6 and leukemia.